1340 BT7455, a fully syntheticBicycletumor-targeted immune cell agonist®, leads to potent EphA2-dependent CD137 agonism and robust anti-tumor efficacy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.